Efficacy and safety of monoclonal antibodies targeting interleukin-5 and interleukin-4/13 pathways in eosinophilic myocarditis: a single-center experience.

30 August 2025 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Translating improved disease understanding to novel therapies in myocardial disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology